Similar articles

• New drugs for rheumatoid arthritis.

  Messori A, Santarlasci B, Vaiani M. Messori A, et al. N Engl J Med. 2004 Aug 26;351(9):937-8. doi: 10.1056/NEJM200408263510922. N Engl J Med. 2004. PMID: 15329436 No abstract available.
• Adalimumab in juvenile rheumatoid arthritis.

  Taddio A, Marchetti F. Taddio A, et al. N Engl J Med. 2008 Dec 4;359(23):2495-6; author reply 2496-7. N Engl J Med. 2008. PMID: 19065749 No abstract available.
• Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?

  O'Dell JR. O'Dell JR. N Engl J Med. 1999 Jan 28;340(4):310-2. doi: 10.1056/NEJM199901283400411. N Engl J Med. 1999. PMID: 9920958 No abstract available.
• Tumor necrosis factor inhibitors for rheumatoid arthritis.

  Scott DL, Kingsley GH. Scott DL, et al. N Engl J Med. 2006 Aug 17;355(7):704-12. doi: 10.1056/NEJMct055183. N Engl J Med. 2006. PMID: 16914706 Review. No abstract available.
• [TNF antagonists in therapy of rheumatoid arthritis].

  Oberpichler-Schwenk H. Oberpichler-Schwenk H. Med Monatsschr Pharm. 1999 Nov;22(11):334-9. Med Monatsschr Pharm. 1999. PMID: 10596266 Review. German. No abstract available.